SE9601421D0 - New composition - Google Patents

New composition

Info

Publication number
SE9601421D0
SE9601421D0 SE9601421A SE9601421A SE9601421D0 SE 9601421 D0 SE9601421 D0 SE 9601421D0 SE 9601421 A SE9601421 A SE 9601421A SE 9601421 A SE9601421 A SE 9601421A SE 9601421 D0 SE9601421 D0 SE 9601421D0
Authority
SE
Sweden
Prior art keywords
pct
sec
date
new composition
pub
Prior art date
Application number
SE9601421A
Other languages
English (en)
Swedish (sv)
Inventor
Arne Brodin
Raymond Fynes
Lars Heijl
Adela Nyqvist-Mayer
Marie Scherlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601421A priority Critical patent/SE9601421D0/xx
Publication of SE9601421D0 publication Critical patent/SE9601421D0/xx
Priority to TW086104109A priority patent/TW473386B/zh
Priority to TR97/01584T priority patent/TR199701584T1/xx
Priority to AU24168/97A priority patent/AU716540B2/en
Priority to RU98100471/14A priority patent/RU2185153C2/ru
Priority to KR1019970709302A priority patent/KR100508601B1/ko
Priority to CA002222676A priority patent/CA2222676C/en
Priority to PCT/SE1997/000566 priority patent/WO1997038675A1/en
Priority to BR9702147A priority patent/BR9702147A/pt
Priority to ES97919826T priority patent/ES2203799T3/es
Priority to DE69724545T priority patent/DE69724545T2/de
Priority to IL12244797A priority patent/IL122447A/en
Priority to CNB971903425A priority patent/CN1149072C/zh
Priority to SK1698-97A priority patent/SK169897A3/sk
Priority to CZ973711A priority patent/CZ371197A3/cs
Priority to DK97919826T priority patent/DK0833612T3/da
Priority to EE9700363A priority patent/EE9700363A/xx
Priority to JP9537002A priority patent/JPH11501678A/ja
Priority to HU9903544A priority patent/HUP9903544A3/hu
Priority to US08/875,888 priority patent/US6031007A/en
Priority to PL97324170A priority patent/PL324170A1/xx
Priority to NZ329246A priority patent/NZ329246A/en
Priority to AT97919826T priority patent/ATE248584T1/de
Priority to EP97919826A priority patent/EP0833612B1/en
Priority to ARP970101317A priority patent/AR006484A1/es
Priority to ZA9703022A priority patent/ZA973022B/xx
Priority to IDP971235A priority patent/ID16420A/id
Priority to IS4618A priority patent/IS4618A/is
Priority to MXPA/A/1997/009941A priority patent/MXPA97009941A/es
Priority to NO19975831A priority patent/NO318239B1/no
Priority to HK98111099A priority patent/HK1010144A1/xx
Priority to JP2003421386A priority patent/JP2004149544A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE9601421A 1996-04-12 1996-04-12 New composition SE9601421D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE9601421A SE9601421D0 (sv) 1996-04-12 1996-04-12 New composition
TW086104109A TW473386B (en) 1996-04-12 1997-03-31 New pharmaceutical composition with anaesthetic effect
EP97919826A EP0833612B1 (en) 1996-04-12 1997-04-01 New pharmaceutical composition with anaesthetic effect
CZ973711A CZ371197A3 (cs) 1996-04-12 1997-04-01 Farmaceutická směs se znecitlivujícím účinkem
JP9537002A JPH11501678A (ja) 1996-04-12 1997-04-01 麻酔作用を有する新規な医薬組成物
RU98100471/14A RU2185153C2 (ru) 1996-04-12 1997-04-01 Новая фармацевтическая композиция с обезболивающим эффектом
KR1019970709302A KR100508601B1 (ko) 1996-04-12 1997-04-01 마취작용을갖는신규제약조성물
CA002222676A CA2222676C (en) 1996-04-12 1997-04-01 New pharmaceutical composition with anaesthetic effect
PCT/SE1997/000566 WO1997038675A1 (en) 1996-04-12 1997-04-01 New pharmaceutical composition with anaesthetic effect
BR9702147A BR9702147A (pt) 1996-04-12 1997-04-01 Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica
ES97919826T ES2203799T3 (es) 1996-04-12 1997-04-01 Nueva composicion farmaceutica con efecto anestesico.
DE69724545T DE69724545T2 (de) 1996-04-12 1997-04-01 Neues arzneimittel mit anästhetischer wirkung
IL12244797A IL122447A (en) 1996-04-12 1997-04-01 An anesthetic pharmaceutical preparation for use on mucous membranes
CNB971903425A CN1149072C (zh) 1996-04-12 1997-04-01 具有麻醉作用的新型药物组合物
SK1698-97A SK169897A3 (en) 1996-04-12 1997-04-01 Pharmaceutical composition with anaesthetic effect
TR97/01584T TR199701584T1 (xx) 1996-04-12 1997-04-01 Anestezi etkili yeni farmas�tik kompozisyon
DK97919826T DK0833612T3 (da) 1996-04-12 1997-04-01 Ny farmaceutisk sammensætning med bedøvende virkning
EE9700363A EE9700363A (et) 1996-04-12 1997-04-01 Uus anesteseeriva toimega farmatseutiline segu
AU24168/97A AU716540B2 (en) 1996-04-12 1997-04-01 New pharmaceutical composition with anaesthetic effect
HU9903544A HUP9903544A3 (en) 1996-04-12 1997-04-01 Pharmaceutical composition with anaesthetic effect for local use
US08/875,888 US6031007A (en) 1996-04-12 1997-04-01 Pharmaceutical composition with anaesthetic effect
PL97324170A PL324170A1 (en) 1996-04-12 1997-04-01 Novel pharmaceutic composition having analgesic effect
NZ329246A NZ329246A (en) 1996-04-12 1997-04-01 Pharmaceutical composition comprising one or more eutectic mixture of lidocaine and prilocaine, surfactants, water and a taste masking agent
AT97919826T ATE248584T1 (de) 1996-04-12 1997-04-01 Neues arzneimittel mit anästhetischer wirkung
ARP970101317A AR006484A1 (es) 1996-04-12 1997-04-02 Composición farmacéutica con efecto anestésico, uso de esta composición para la fabricación de medicamentos, y proceso para la fabricación de esta composición .
ZA9703022A ZA973022B (en) 1996-04-12 1997-04-09 New pharmaceutical composition with anaesthetic effect.
IDP971235A ID16420A (id) 1996-04-12 1997-04-14 Komposisi farmasi baru dengan efek anastesia
IS4618A IS4618A (is) 1996-04-12 1997-11-21 Ný lyfjablanda sem hefur deyfandi áhrif
MXPA/A/1997/009941A MXPA97009941A (es) 1996-04-12 1997-12-09 Nueva composicion farmaceutica con efecto anestesico
NO19975831A NO318239B1 (no) 1996-04-12 1997-12-11 Farmasoytisk preparat med anestetisk virkning, fremgangsmate for fremstilling av samme og anvendelse for fremstilling av medikament.
HK98111099A HK1010144A1 (en) 1996-04-12 1998-10-05 New pharmaceutical composition with anaesthetic effect
JP2003421386A JP2004149544A (ja) 1996-04-12 2003-12-18 麻酔作用を有する新規な医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601421A SE9601421D0 (sv) 1996-04-12 1996-04-12 New composition

Publications (1)

Publication Number Publication Date
SE9601421D0 true SE9601421D0 (sv) 1996-04-12

Family

ID=20402194

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601421A SE9601421D0 (sv) 1996-04-12 1996-04-12 New composition

Country Status (30)

Country Link
US (1) US6031007A (es)
EP (1) EP0833612B1 (es)
JP (2) JPH11501678A (es)
KR (1) KR100508601B1 (es)
CN (1) CN1149072C (es)
AR (1) AR006484A1 (es)
AT (1) ATE248584T1 (es)
AU (1) AU716540B2 (es)
BR (1) BR9702147A (es)
CA (1) CA2222676C (es)
CZ (1) CZ371197A3 (es)
DE (1) DE69724545T2 (es)
DK (1) DK0833612T3 (es)
EE (1) EE9700363A (es)
ES (1) ES2203799T3 (es)
HK (1) HK1010144A1 (es)
HU (1) HUP9903544A3 (es)
ID (1) ID16420A (es)
IL (1) IL122447A (es)
IS (1) IS4618A (es)
NO (1) NO318239B1 (es)
NZ (1) NZ329246A (es)
PL (1) PL324170A1 (es)
RU (1) RU2185153C2 (es)
SE (1) SE9601421D0 (es)
SK (1) SK169897A3 (es)
TR (1) TR199701584T1 (es)
TW (1) TW473386B (es)
WO (1) WO1997038675A1 (es)
ZA (1) ZA973022B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
AU759641B2 (en) * 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
KR100416646B1 (ko) * 2000-08-14 2004-02-05 구주제약주식회사 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물
GB0120701D0 (en) 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
US20040087520A1 (en) * 2002-10-25 2004-05-06 Chowdhury Dipak K. Compositions and methods for delivery of therapeutic agents
TW200410717A (en) * 2002-12-31 2004-07-01 Ind Tech Res Inst Delivery system for control release of temperature sensitive bioactive material
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
BR0301968A (pt) * 2003-05-22 2005-06-28 Cristalia Prod Quimicos Farm Misturas eutéticas ternárias e quaternárias constituìdas por substâncias anestésicas locais, seu emprego no preparo de composições farmacêuticas e seu uso em anestesia e analgesia tópica
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
US20050123596A1 (en) * 2003-09-23 2005-06-09 Kohane Daniel S. pH-triggered microparticles
US7943179B2 (en) * 2003-09-23 2011-05-17 Massachusetts Institute Of Technology pH triggerable polymeric particles
US20070232695A1 (en) * 2004-01-28 2007-10-04 Collegium Pharmaceutical, Inc. Gelled Periodontal Anesthetic Preparation
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US20090123527A1 (en) * 2006-07-24 2009-05-14 Akorn, Inc. Method of inducing topical anesthesia and transdermal patch
US20080021068A1 (en) 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US20130045238A1 (en) * 2009-04-22 2013-02-21 Agency For Science, Technology And Research Emulsions for transdermal delivery
WO2011074015A2 (en) 2009-12-17 2011-06-23 Themis Medicare Limited Novel composition of pharmaceutical product to treat sexual dysfunction
BR112012017554B8 (pt) 2010-01-14 2021-05-25 Crescita Therapeutics Inc formulações de anestésicas locais formadoras de sólido para controle da dor
WO2011121034A2 (en) 2010-04-01 2011-10-06 Pharmanest Ab Water-free pharmaceutical compositions suitable for local anaesthetics
AU2011234415C1 (en) 2010-04-01 2014-07-10 Pharmanest Ab Bioadhesive compositions of local anaesthetics
SI2552487T1 (sl) 2010-04-01 2017-02-28 Pharmanest Ab Termo-gelirni anestetski sestavki
KR20120118495A (ko) * 2010-04-21 2012-10-26 테이코쿠 팔마 유에스에이, 인코포레이티드 국부 마취제 에멀전 조성물 및 이의 제조 및 사용 방법
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
CA2914608A1 (en) * 2013-03-14 2014-09-25 Jsn I, Llc Taste masking of anesthetics and analgesics
WO2017039559A1 (en) 2015-09-02 2017-03-09 T.C. Istanbul Medipol Universitesi Formulations of benzocaine loaded microemulsion based hydrogels for therapeutic purposes and their production method
WO2020182535A1 (en) 2019-03-08 2020-09-17 Bayer Oy Uterine sound tube with anaesthetic applicator
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
US5292516A (en) * 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
CA2040460C (en) * 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
FR2704429B3 (fr) * 1993-04-30 1995-07-13 Algovital Sarl Formulation associant une réaction alcaline et des composants d'huiles essentielles pour réaliser une anesthésie locale, par voie externe, transcutanée, sans injection.
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof

Also Published As

Publication number Publication date
PL324170A1 (en) 1998-05-11
HK1010144A1 (en) 1999-06-17
ZA973022B (en) 1997-10-13
NO975831L (no) 1997-12-11
AU2416897A (en) 1997-11-07
WO1997038675A1 (en) 1997-10-23
NO975831D0 (no) 1997-12-11
JP2004149544A (ja) 2004-05-27
CN1188407A (zh) 1998-07-22
KR19990022833A (ko) 1999-03-25
DE69724545T2 (de) 2004-06-03
KR100508601B1 (ko) 2006-03-23
EE9700363A (et) 1998-06-15
EP0833612B1 (en) 2003-09-03
CA2222676C (en) 2008-01-22
CN1149072C (zh) 2004-05-12
AR006484A1 (es) 1999-08-25
IS4618A (is) 1997-11-21
NZ329246A (en) 2000-06-23
US6031007A (en) 2000-02-29
IL122447A (en) 2001-04-30
AU716540B2 (en) 2000-02-24
HUP9903544A2 (hu) 2000-06-28
HUP9903544A3 (en) 2000-07-28
TR199701584T1 (xx) 1999-03-22
DK0833612T3 (da) 2003-12-01
BR9702147A (pt) 1999-07-20
SK169897A3 (en) 1998-07-08
MX9709941A (es) 1998-03-29
NO318239B1 (no) 2005-02-21
CA2222676A1 (en) 1997-10-23
JPH11501678A (ja) 1999-02-09
CZ371197A3 (cs) 1998-06-17
ES2203799T3 (es) 2004-04-16
IL122447A0 (en) 1998-06-15
RU2185153C2 (ru) 2002-07-20
ID16420A (id) 1997-09-25
DE69724545D1 (de) 2003-10-09
TW473386B (en) 2002-01-21
ATE248584T1 (de) 2003-09-15
EP0833612A1 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
SE9601421D0 (sv) New composition
FI970101A0 (fi) Uusi farmaseuttinen valmiste kivun hallintaan
DE69531457D1 (en) Sulfonamide
BR9612661A (pt) Utilização de uma combinaç i de tensoatives agentes quelantes e óleos essenciais para desinfecção eficaz
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
NO901031L (no) Baktericid sammensetning.
SE8602241L (sv) Hudregenererande och hydratiserande kosmetiska kompositioner och forfarande for framstellning av den aktiva ingrediensen
DE59509472D1 (de) Spender für eine folienförmige reinigungs- und pflegezubereitung
FI963394A (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
DE69119588D1 (de) Verwendung von ketorolac zur behandlung von periodontitis
ZA965749B (en) Use of allylamines.
MD980129A (en) Antiherpetic remedy
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
KR970019821A (ko) 송진을 함유한 치약 제조 방법
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
SE9403861D0 (sv) Novel medicinal use
UA30250A (uk) Антиоксидантний засіб